A Multiple Dose Safety Study of PEG-IFN in Healthy Volunteers

NCT02125578 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BIIB017 (PEGylated Interferon Beta-1a)
DRUG: Placebo

Sponsor

Biogen